NYSEARCA:IBDS iShares iBonds Dec 2027 Term Corporate ETF (IBDS) Price, Holdings, & News → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free IBDS Stock Alerts $23.54 -0.02 (-0.08%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$23.49▼$23.5450-Day Range$23.47▼$23.8452-Week Range$22.80▼$24.06Volume193,718 shsAverage Volume433,719 shsMarket Capitalization$2.26 billionAssets Under Management$2.27 billionDividend Yield2.85%Net Expense Ratio0.10% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOwnershipStock AnalysisChartDividendHeadlinesHoldingsOwnership Get iShares iBonds Dec 2027 Term Corporate ETF alerts: Email Address About iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS)The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock.Read More IBDS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBDS ETF News HeadlinesMarch 4, 2024 | msn.comiShares iBonds Dec 2027 Term Corporate ETF declares monthly distribution of $0.0839February 7, 2024 | finance.yahoo.comiShares iBonds Dec 2027 Term Corporate ETF (IBDS)April 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.December 23, 2023 | seekingalpha.comIBDS iShares iBonds Dec 2027 Term Corporate ETFDecember 22, 2023 | msn.comiShares Interest Rate Hedged Long-Term Corporate Bond ETF declares monthly distribution of $0.1694December 2, 2023 | msn.comiShares iBonds Dec 2029 Term Treasury ETF declares monthly distribution of $0.0682November 21, 2023 | investing.comIBDS ETF Stock Price HistoryOctober 14, 2023 | investing.comiShares iBonds Oct 2027 Term TIPS ETF (IBID)April 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.August 2, 2023 | msn.comiShares iBonds Dec 2028 Term Corporate ETF declares monthly distribution of $0.0871See More Headlines Receive IBDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares iBonds Dec 2027 Term Corporate ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares iBonds Dec 2027 Term Corporate ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IBDS Inception Date9/12/2017 Fund ManagerJames Mauro, Scott Radell WebN/A PhoneN/AFund Focus Asset ClassFixed Income BenchmarkBloomberg December 2027 Maturity Corporate Index (USD) CategoryCorporate FocusInvestment Grade Development LevelDeveloped Markets RegionNorth America Number of Holdings604 Fund Statistics Assets Under Management$2.27 billion Average Daily Volume$304,671.80 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest90,100 shs Miscellaneous Outstanding Shares95,950,000Beta0.08 Creation Unit50,000 Creation Fee$300.00 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> iShares iBonds Dec 2027 Term Corporate ETF ExpensesTypeIBDSInvestment Grade ETFsFixed Income ETFsNYSEARCA ETFsAll ETFsManagement Fee0.10%0.22%0.32%0.50%0.51%Other Expenses0.00%0.12%0.27%0.64%0.58%Total Expense0.10%0.25%0.40%0.74%0.70%Fee Waiver0.00%-0.15%-0.24%-0.68%-0.57%Net Expense0.10%0.22%0.35%0.58%0.58% iShares iBonds Dec 2027 Term Corporate ETF (IBDS) Holdings & ExposureTop 10 IBDS HoldingsT-MOBILE USA INC - 3.75 2027-04-15Holding Weight: 0.82%CITIGROUP INC - 4.45 2027-09-29Holding Weight: 0.79%WARNERMEDIA HOLDINGS INC - 3.75 2027-03-15Holding Weight: 0.78%MICROSOFT CORPORATION - 3.3 2027-02-06Holding Weight: 0.71%VERIZON COMMUNICATIONS INC - 4.13 2027-03-16Holding Weight: 0.67%GOLDMAN SACHS GROUP INC/THE - 3.85 2027-01-26Holding Weight: 0.62%AMAZON.COM INC - 3.15 2027-08-22Holding Weight: 0.60%BROADCOM CORPORATION/BROADCOM CAYM - 3.88 2027-01-15Holding Weight: 0.59%MORGAN STANLEY - 3.63 2027-01-20Holding Weight: 0.59%META PLATFORMS INC MTN - 3.5 2027-08-15Holding Weight: 0.55%IBDS Sector ExposureIBDS Industry ExposureFull Holdings Details Similar ETFsFidelity Total Bond ETFNYSEARCA:FBNDSPDR Bloomberg Barclays Investment Grade Floating Rate ETFNYSEARCA:FLRNiShares 10+ Year Investment Grade Corporate Bond ETFNYSEARCA:IGLBiShares 0-5 Year Investment Grade Corporate Bond ETFNASDAQ:SLQDiShares iBonds Dec 2026 Term Corporate ETFNYSEARCA:IBDRInstitutional OwnershipCambridge Investment Research Advisors Inc.Bought 4,777 shares on 4/25/2024Ownership: 0.079%Leavell Investment Management Inc.Bought 13,919 shares on 4/24/2024Ownership: 0.081%First Fiduciary Investment Counsel Inc.Bought 6,822 shares on 4/24/2024Ownership: 0.062%Exchange Capital Management Inc.Bought 8,759 shares on 4/18/2024Ownership: 0.048%Buffington Mohr McNealBought 5,098 shares on 4/18/2024Ownership: 0.029%View All Institutional Transactions IBDS ETF - Frequently Asked Questions How have IBDS shares performed in 2024? iShares iBonds Dec 2027 Term Corporate ETF's stock was trading at $23.93 at the start of the year. Since then, IBDS stock has decreased by 1.6% and is now trading at $23.54. View the best growth stocks for 2024 here. How often does iShares iBonds Dec 2027 Term Corporate ETF pay dividends? What is the dividend yield for iShares iBonds Dec 2027 Term Corporate ETF? iShares iBonds Dec 2027 Term Corporate ETF declared a dividend on Wednesday, November 22nd. Shareholders of record on Tuesday, April 2nd will be paid a dividend of $0.0857 per share on Friday, April 5th. The ex-dividend date is Monday, April 1st. This is a positive change from the stock's previous dividend of $0.08. Read our dividend analysis for IBDS. What does IBDS invest in? iShares iBonds Dec 2027 Term Corporate ETF is a fixed income fund issued by iShares. IBDS focuses on investment grade investments and follows the Bloomberg December 2027 Maturity Corporate Index (USD). The fund's investments total to approximately $2.27 billion assets under management. What is the management fee for iShares iBonds Dec 2027 Term Corporate ETF? iShares iBonds Dec 2027 Term Corporate ETF's management fee is 0.10% and has no other recorded expenses or fee waivers. The net expense ratio for IBDS is 0.10%. What other stocks do shareholders of iShares iBonds Dec 2027 Term Corporate ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares iBonds Dec 2027 Term Corporate ETF investors own include CenterPoint Energy (CNP), Chevron (CVX), Eagle Point Credit (ECC), Ford Motor (F), General Electric (GE), SPDR S&P Global Natural Resources ETF (GNR), iShares Core S&P Mid-Cap ETF (IJH), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI) and L Brands (LB). Who are iShares iBonds Dec 2027 Term Corporate ETF's major shareholders? iShares iBonds Dec 2027 Term Corporate ETF's stock is owned by many different institutional and retail investors. Top institutional investors include RVW Wealth LLC (1.21%), Praetorian Wealth Management Inc. (0.32%), Confluence Investment Management LLC (0.29%), Leavell Investment Management Inc. (0.08%), Cambridge Investment Research Advisors Inc. (0.08%) and First Fiduciary Investment Counsel Inc. (0.06%). How do I buy shares of iShares iBonds Dec 2027 Term Corporate ETF? Shares of IBDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:IBDS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares iBonds Dec 2027 Term Corporate ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
